AIM Pharmakon (API) Announced a New Proprietary Premium-Quality Natural Concentrated Liquid Calcium and Mineral Supplement Now Available Direct to... (ddress this set of challenges. AimCa++DO...)

HOME >> BIOLOGY >> TECHNOLOGY

AIM Pharmakon (API) Announced a New Proprietary Premium-Quality Natural Concentrated Liquid Calcium and Mineral Supplement Now Available Direct to Consumers

Date:1/26/2009

ddress this set of challenges. AimCa++DONAN (TM) is a non-acidic, non-dairy, and non-protein source of calcium for bone and dental health. The alkaline nature of the product ensures that it is gentle on gastro-intestinal tract for people with GERD," commented Vijay Puntambekar, President of AIM Pharmakon.

AimCa++DONAN (TM) in a liquid concentrate matrix is the product of choice due to its efficacy, ease of intake, high bioavailability, and palatability," commented Vijay Puntambekar. AimCa++DONAN (TM) contains DONAN (TM) from Coral International Co., Ltd., Japan, which has exceptionally high elemental calcium content, essential minerals and trace mineral profile contributing to elevated mineral availability. Recent studies in Japan have shown that aragonite-type calcium of coral origin is better absorbed through the intestine than calcium of calcium carbonate, oyster shell calcium, or eggshell origin. The product has a low glycemic value and is suitable for people with diabetes. This product contains Nuti-Masu from Nuchi Masu Co., Ltd, a sea-salt mineral and SunSea ionized mineral complex from Coral International, Co., Ltd. Both ingredients are supplied exclusively to API and are essential components of proprietary bioenhancing AIMix Sorb mix. The synergistic balance of minerals and soluble fiber helps achieve the optimum bone health advantages of AimCa++DONAN (TM) along with a balanced diet and exercise.

"The innovative products of AIM Pharmakon are highly efficacious and an exceptionally high-benefit-to-cost ratio for athletes, women, baby-boomers, and seniors," added Vijay Puntambekar. "We are proud to be recognized for developing preservative-free, hard-to-formulate products. API made significant strides in addressing the specific supplement needs for active lifestyles, seniors and people with challenged immunity levels. Our core competence and aim is: Formulating Innovation," he continued.

API develops and m
'/>"/>

SOURCE AIM Pharmakon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
2. Panelists Announced for 2007 Manufacturers Forum
3. Velos eResearch System License Agreement Announced
4. Biotech Hall of Fame Inductees Announced
5. MyClyns(TM), a New Standard of Personal Protection, is Announced at the EMS and Firehouse Central EXPO
6. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
7. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
8. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
9. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
10. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
11. Come Home to Kansas Announced by KTEC

Post Your Comments:

(Date:6/19/2013)... WASHINGTON, D.C. (PRWEB) June 19, 2013 ... with its first Bayer Bee Care Community Leadership Award. ... Pollinator Week Congressional Reception in Washington, D.C., an ... pollinators make to the world’s food supply. , ... who have harnessed the power of the honey bee ...

(Date:6/19/2013)... 19, 2013 BioConvergence team members ... faculty at 2013’s BioLogistics Summit in San Francisco ... by Cold Chain IQ and IQPC, addressed the ... is, in part, attributed to current trends of ... within these trends is an increase in movement, ...

(Date:6/19/2013)... (PRWEB) June 19, 2013 Express Diagnostics ... tests, today announced that it has received Class III ... and sell its DrugCheck® NxStep Onsite Drug Screen ... of the rapid screening device in near-patient settings, such ... Screen Cup received Health Canada Class III approval for ...

(Date:6/18/2013)... China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... preliminary unaudited financial results for the fourth quarter and ... 2013. Fourth Quarter of Fiscal 2013 ... fiscal 2013 increased by 33.3% to RMB133.0 million ($21.4 ...

[0] Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award [0] BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment [0] Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013

... TROMS0, Norway and SEOUL, Korea, June 19 ... KAEL-GemVax,today announced the signing of a collaborative agreement to ... for the treatment of,cancer. , ... CEO Jay,Sangjae Kim, "We are delighted to announce this ...

... research from Cincinnati Children,s Hospital Medical Center highlights the critical ... embryonic development on formation of a normal heart and skull. ... Proceedings of the National Academy of Sciences , a ... the gene/protein SHP2 interferes with the normal developmental activity of ...

... Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biopharmaceutical ... HIV-1 (Human Immunodeficiency Virus), and other infectious agents, announced ... cooperative arrangement with Cook County Board President Todd H. ... County Health and Hospitals Systems Board ("Health System"); and ...

Cached Biology Technology:Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy 2 Scientists identify gene vital to early embryonic cells forming a normal heart and skull 2 GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois 2 GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois 3 GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois 4 GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois 5

Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy Scientists identify gene vital to early embryonic cells forming a normal heart and skull GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois

(Date:6/18/2013)... chemical modification of DNA and this modification can ... sequence. Until now, scientists believed that this epigenetic ... Today, a team of researchers from the University ... Louis-Jeantet Professor at the Faculty of Medicine, reveals ... that DNA methylation may play both a passive ...

(Date:6/17/2013)... a new virus in patients with severe brain infections ... the virus is responsible for the symptoms of disease. ... 28 out of 644 patients with severe brain infections ... in any of the 122 patients with non-infectious brain ... and central nervous system are often fatal and patients ...

(Date:6/17/2013)... foundations with more modern elements. Using this same approachbut ... Dietrich School of Arts and Sciences have designed a ... storage, and gas transport more efficient and at a ... issue of the Journal of the American Chemical ... builds upon Pitt Associate Professor of Chemistry Nathaniel Rosi,s ...

Breaking Biology News(10 mins):The secret of DNA methylation 2 New virus isolated from patients with severe brain infections 2 New virus isolated from patients with severe brain infections 3 'Chemical architects' build materials with potential applications in drug delivery and gas storage 2

[0] The secret of DNA methylation [0] New virus isolated from patients with severe brain infections [0] 'Chemical architects' build materials with potential applications in drug delivery and gas storage

... 12 collaborating institutions have been awarded $24 million in ... for Environmental Implications of Nanotechnology (UC CEIN), which will ... The center, to be housed ... campus, will explore the impact of nanomaterials on life ...

... DURHAM, NC--The National Science Foundation (NSF) and the Environmental ... the Center for Environmental Implications of NanoTechnology (CEINT) to ... Nanoparticles are as much as a million times smaller ... properties compared with larger objects made from the same ...

... University of North Carolina at Chapel Hill School of Medicine ... insulin, the hormone used to treat diabetes. The ... a cure for the millions of people affected by the ... into pluripotent stem cells, or cells that can give rise ...

Cached Biology News:UCLA, partners establish new center on environmental effects of nanotechnology 2 UCLA, partners establish new center on environmental effects of nanotechnology 3 UCLA, partners establish new center on environmental effects of nanotechnology 4 Duke to lead new NSF, EPA center to study the environmental implications of nanotechnology 2 Duke to lead new NSF, EPA center to study the environmental implications of nanotechnology 3 UNC scientists turn human skin cells into insulin-producing cells 2

UCLA, partners establish new center on environmental effects of nanotechnology Duke to lead new NSF, EPA center to study the environmental implications of nanotechnology UNC scientists turn human skin cells into insulin-producing cells

... These 2-D standards consist of seven ... inhibitor, bovine carbonic anhydrase, rabbit muscle GAPDH, ... white conalbumin) with pIs ranging from 4.5 ... 17,500 to 76,000. These 2-D standards provide ...

... includes 2 tube gel adaptors, 24 ... length), gaskets, grommets, stoppers. The PROTEAN II ... cell offer the versatility to perform a ... second-dimension 2-D electrophoresis, native, preparative, and gradient ...

The PROTEAN II xi multi-cell 2-D conversion kit converts the PROTEAN II xi multi-cell to the PROTEAN II XL multi-cell for a wider format cell that accepts 17 to 18 cm IPG strips....

StemSep Anti-Phycoertherin Tetrameric Antibody Complexes, 2 mL for labeling 1x10 9 cells. Cross-linking Reagent for StemSep Separations of Cells Labeled with PE-conjugated Antibody....

Biology Products:

2-D SDS-PAGE Standards, 500 microliter from Bio-Rad PROTEAN II xi Cell 2-D Conversion Kit. from Bio-Rad PROTEAN II xi Multi-Cell 2-D Conversion Kit from Bio-Rad StemSep Anti-Phycoertherin TAC, 2 mL from StemCell Technologies, Inc.